Coloplast A/S reported a slight drop in its fiscal first-quarter net profit.
The Danish healthcare equipment manufacturer booked 940 million Danish kroner, or 4.42 kroner per share, in net profit for the three months ended Dec. 31, 2017. This compares to 946 million kroner, or 4.46 kroner per share, in the comparable quarter of the last fiscal year.
The S&P Capital IQ normalized EPS consensus estimate for the fiscal first quarter was 4.55 Danish kroner.
Coloplast booked fiscal first-quarter revenue of 3.96 billion kroner, up 5% year over year.
In other news, the company's board approved a new 1 billion kroner share buyback program.
Coloplast also said it acquired France-based Lilial, a distributor of catheters and ostomy supplies, for €35.5 million in early January.
As of Jan. 31, US$1 was equivalent to 5.98 Danish kroner.
